Trademark: 98165301
Word
BRAVNETSA
Status Date
Thursday, May 2, 2024
Filing Date
Tuesday, September 5, 2023
Published for Opposition
Tuesday, June 4, 2024
5 Radiopharmaceutical product for the treatment of cancer; radiopharmaceutical compounds for the treatment of neuroendocrine tumors; pharmaceutical preparations for the treatment of somatostatin receptor-positive neuroendocrine tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders
Sep 8, 2023
New Application Entered
Sep 28, 2023
New Application Office Supplied Data Entered
May 1, 2024
Approved For Pub - Principal Register
May 1, 2024
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24